During the past decade, HOPE Research Institute conducted 38 clinical trials. In the 10-year time frame, 38 clinical trials started and 51 clinical trials were completed, i.e. on average, 134.2% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 23 clinical trials were completed. i.e. 104.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HOPE Research Institute" #1 sponsor was "Pfizer" with 12 trials, followed by "Endo Pharmaceuticals" with 7 trials sponsored, "Boston Scientific Corporation" with 6 trials sponsored, "3M" with 3 trials sponsored and "Genzyme, a Sanofi Company" with 3 trials sponsored. Other sponsors include 83 different institutions and companies that sponsored additional 73 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HOPE Research Institute" #1 collaborator was "Pfizer" with 5 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Premier Research Group plc" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "HOPE Research Institute" are "Alzheimer's Disease" (7 trials), "Chronic Pain" (5 trials), "Multiple Sclerosis" (4 trials), "Alzheimer Disease" (3 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "HOPE Research Institute" in a lesser frequency.

Most popular intervention types in "HOPE Research Institute" are "Drug" (64 trials), "Biological" (32 trials), "Device" (20 trials), "Other" (10 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "placebo" (7 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Saline" (3 trials) and "13vPnC" (2 trials). Other intervention names were less common.

The vast majority of trials in "HOPE Research Institute" are 112 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "HOPE Research Institute". undefined are not yet recruiting, 6 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 89 completed trials in HOPE Research Institute, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in HOPE Research Institute, 5 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 13 trials that are defined as “Not Applicable".